← Back to Search

CGM for Type 2 Diabetes Risk Evaluation

N/A
Waitlist Available
Led By Mary Ellen Vajravelu, MD, MSHP
Research Sponsored by Mary Ellen Vajravelu
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes
Awards & highlights

Study Summary

This trial will compare the results of a Continuous Glucose Monitor to the standard 2-hour Oral Glucose Tolerance Test in order to see if the CGM is a safe, effective, and acceptable way to evaluate type 2 diabetes risk in youth.

Eligible Conditions
  • Insulin Resistance
  • Prediabetes
  • Obesity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of CGM use to determine Type 2 Diabetes Risk
Secondary outcome measures
Acceptability of CGM use for at-home T2D risk evaluation in youth
Negative predictive value of at-home, CGM-measured glucose challenge
Glucose
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: CGM use for T2D risk evaluationExperimental Treatment1 Intervention
All participants will complete a standard 2-hour oral glucose tolerance test (OGTT), wear a CGM for 10 days, complete at-home glucose challenge, and provide qualitative feedback about their experiences with both OGTT and CGM use for risk evaluation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CGM
2013
N/A
~1010

Find a Location

Who is running the clinical trial?

Mary Ellen VajraveluLead Sponsor
Mary Ellen Vajravelu, MDLead Sponsor
Mary Ellen Vajravelu, MD, MSHPPrincipal InvestigatorUniversity of Pittsburgh

Media Library

CGM use for T2D risk evaluation Clinical Trial Eligibility Overview. Trial Name: NCT05404711 — N/A
Insulin Resistance Research Study Groups: CGM use for T2D risk evaluation
Insulin Resistance Clinical Trial 2023: CGM use for T2D risk evaluation Highlights & Side Effects. Trial Name: NCT05404711 — N/A
CGM use for T2D risk evaluation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05404711 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have enrolled in this clinical research?

"Yes, the evidence on clinicaltrials.gov confirms that this investigation is presently looking for participants. This trial was first launched on October 11th 2022 and has since been updated as of October 18th 2022; it requires 40 individuals to enroll from 1 medical centre."

Answered by AI

Are you currently accepting volunteers for this clinical trial?

"Affirmative. Clinicaltrials.gov reveals that this research is actively seeking volunteers; it was initially posted on October 11th 2022 and the details were most recently updated on the 18th of said month. The program requires 40 participants to be gathered from one medical site in total."

Answered by AI

What criteria must be met for an individual to qualify for participation in this research?

"This ongoing clinical trial is seeking 40 participants aged between 8 and 18 who display signs of insulin resistance. All recruits must fulfil the following criteria: gender-neutral, Tanner 2 or higher pubertal development, overweight/obese (BMI≥85th percentile for age and sex OR ≥ 25kg/m2 in those over 18 years), within 6 months have had abnormal HbA1c levels, fasting glucose scores >100mg/dL, OGTT plasma glucose scores above 140 mg/DL; they also need to belong to one of the specified races - Black, Hispanic Asian Native American Pacific Islander - have dyslip"

Answered by AI

Does this trial accept applicants aged under 50?

"As established by the inclusion criteria, eligible participants for this medical trial must be between 8 and 18 years old. In total, there are 80 studies pertaining to those under 18 while 352 studies have been conducted on people over 65."

Answered by AI
~16 spots leftby Apr 2025